Clinical trial · Interventional
Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy
Early Electroacupuncture for Urinary Continence After Radical Prostatectomy: A Randomized, Single-Blind, Sham-Electroacupuncture-Controlled, Parallel-Group, Multicenter Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial aims to find out if early electroacupuncture (EA) helps people recover the ability to control urination and is safe after surgery to remove the prostate gland for prostate cancer (radical prostatectomy). Participants are people aged 18 to 80 with localized prostate cancer who have had radical prostatectomy and are in good physical condition (ECOG score 0-1, meaning they can manage daily activities well). It will answer two key questions: Does early EA make more people fully control their urination 3 months after prostate surgery? How does early EA affect urination control and safety at 1, 6, and 12 months after surgery? Researchers will compare two groups: one getting EA and the other getting a fake version (sham EA ) to see if EA works better. Participants will start treatment 1 week after surgery, getting EA or sham EA 3 times a week for 6 weeks, 20 minutes each time. They will also complete tests to check urination control and fill out surveys about their urination, quality of life, and symptoms at different times. Their safety will be watched closely too.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Electroacupuncture | Procedure | — | UNRESOLVED |
| Sham Electroacupuncture | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Electroacupuncture Group
- description
- Patients in this group will receive electroacupuncture intervention starting from 1 week after radical prostatectomy, following a standardized treatment schedule to assess its effect on postoperative urinary continence recovery.
- interventionNames
- Procedure: Electroacupuncture
- type
- PLACEBO_COMPARATOR
- label
- Sham Electroacupuncture Group
- description
- Patients in this group will receive sham electroacupuncture intervention with the same treatment schedule and duration as the electroacupuncture group, to serve as a placebo control and ensure the validity of the trial results.
- interventionNames
- Procedure: Sham Electroacupuncture
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients aged 18 to 80 years (inclusive) with a diagnosis of localized prostate cancer scheduled for radical prostatectomy. 2. Clinical tumor stage ≤ cT2bN0M0 confirmed by preoperative evaluation. 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. 4. Willingness to participate in the study and provision of written informed consent. Exclusion Criteria: 1. Presence of preoperative detrusor overactivity, urethral stricture, urge urinary incontinence, stress urinary incontinence, or overflow urinary incontinence. 2. Preoperative International Prostate Symptom Score (IPSS) ≥ 20. 3. Concurrent urogenital infectious diseases (e.g., acute urethritis, acute cystitis). 4. History of pelvic radiotherapy. 5. Previous prostate surgery. 6. Severe cardiovascular disease, hepatic or renal dysfunction, or coagulation disorders. 7. Presence of psychiatric or psychological conditions impairing the ability to provide coherent feedback. 8. Receipt of any acupuncture treatment within one month prior to the study. 9. Needle phobia, history of fainting during acupuncture, or strong aversion to acupuncture therapy. 10. Any other condition considered by the investigators to render the patient unsuitable for study participation.
References
Publications (0)
Data not yet available